UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014342
Receipt number R000016674
Scientific Title Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention
Date of disclosure of the study information 2014/07/01
Last modified on 2017/07/24 16:15:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention

Acronym

Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention

Scientific Title

Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention

Scientific Title:Acronym

Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary intervention

Region

Japan


Condition

Condition

coronary artery disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the effect of the cholesterol-lowering effect on cardiac events

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Major adverse cardiac events
cardiovascular death
non-fatal acute coronary syndrome
non-fatal stroke
target vascular revascularization

Key secondary outcomes

admission by congestive heart failure etc.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Distribution to rosuvastatin 5mg/day for 9 months

Interventions/Control_2

Distribution to atorvastatin 10mg/day for 9 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Coronary artery disease patinets treated with percutaneous coronary intervention
(2) Patients with LDL-cholesterol>100mg/dl

Key exclusion criteria

(1)Patients who developed acute myocardial infarction within 30days from percutaneous coronary intervention
(2)Patinets who had been treated with percutaneous coronary intervention
(3)Patients treated with fibrate-based medicine
(4)Patients treated with hemodyalysis
(5)Patients diagnosed with familial hypercholesterolemia
(6)Patients who developed stroke within 3 months from percutaneous coronary intervention
(7)Patients having liver damage
(8)Patients having renal damage
(9)Patients having high level of serum creatine phosphokinase
(10)Patients treated with cyclosporin
(11)Pregnant patients
(12)Patients with hypothyroidism or muscular disorder
(13)Drug abuse and alcoholic patients
(14)Patients having carcinoma
(15)Patients having severe complications
(16)Patients having allergy of rosuvastatin or atorvastatin

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yokoyama Hiroaki

Organization

Hirosaki University Graduate School of Medicine

Division name

Cardiology

Zip code


Address

Zaifu-cho 5, Hirosaki, Japan

TEL

0172-39-5057

Email

hero8686@cc.hirosaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yokoyama Hiroaki

Organization

Hirosaki University Graduate School of Medicine

Division name

Cardiology

Zip code


Address

Zaifu-cho 5, Hirosaki, Japan

TEL

0172-39-5057

Homepage URL


Email

hero8686@cc.hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学大学院医学研究科(青森県)


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2013 Year 11 Month 30 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2016 Year 05 Month 01 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 23 Day

Last modified on

2017 Year 07 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016674


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name